{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T16:32:53Z","timestamp":1785256373028,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T00:00:00Z","timestamp":1737763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["AYG2024QNA40"],"award-info":[{"award-number":["AYG2024QNA40"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic research project of Shanghai Sixth People's Hospital","award":["ynqn202310"],"award-info":[{"award-number":["ynqn202310"]}]},{"name":"Shanghai Key Clinical Specialty","award":["shslczdzk03203"],"award-info":[{"award-number":["shslczdzk03203"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-024-04792-w","type":"journal-article","created":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T04:51:49Z","timestamp":1737780709000},"page":"3827-3835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of clinically significant prostate cancer undercategorized by multiparametric magnetic resonance imaging"],"prefix":"10.1007","volume":"50","author":[{"given":"Wangshu","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijia","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caixia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,25]]},"reference":[{"issue":"1","key":"4792_CR1","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.eururo.2014.10.026","volume":"68","author":"M Valerio","year":"2015","unstructured":"Valerio M, Donaldson I, Emberton M, et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. Eur Urol. 2015; 68(1): 8\u201319.","journal-title":"Eur Urol"},{"issue":"11","key":"4792_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/cncr.30548","volume":"123","author":"WS Lai","year":"2017","unstructured":"Lai WS, Gordetsky JB, Thomas JV, Nix JW, Rais-Bahrami S. Factors predicting prostate cancer upgrading on magnetic resonance imaging-targeted biopsy in an active surveillance population. Cancer. 2017; 123(11): 1941\u201348.","journal-title":"Cancer"},{"issue":"2","key":"4792_CR3","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1148\/radiol.2019182946","volume":"292","author":"AR Padhani","year":"2019","unstructured":"Padhani AR, Barentsz J, Villeirs G, et al. PI-RADS Steering Committee: The PI-RADS multiparametric MRI and MRI-directed biopsy pathway. Radiology. 2019; 292(2):464\u201374.","journal-title":"Radiology"},{"issue":"10071","key":"4792_CR4","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017; 389(10071):815\u201322.","journal-title":"Lancet"},{"issue":"1","key":"4792_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1148\/radiol.2017152877","volume":"86","author":"S Borofsky","year":"2018","unstructured":"Borofsky S, George AK, Gaur S, et al. What are we missing? false-negative cancers at multiparametric MR imaging of the prostate. Radiology. 2018; 86(1):186\u201395.","journal-title":"Radiology"},{"issue":"4","key":"4792_CR6","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1007\/s00330-015-3894-x","volume":"26","author":"PJ De Visschere","year":"2016","unstructured":"De Visschere PJ, Naesens L, Libbrecht L, et al. What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging? Eur Radiol. 2016; 26(4):1098\u20131107.","journal-title":"Eur Radiol"},{"issue":"2","key":"4792_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.juro.2018.08.046","volume":"201","author":"M Oishi","year":"2019","unstructured":"Oishi M, Shin T, Ohe C, et al. Which patients with negative magnetic resonance imaging can safely avoid biopsy for prostate cancer? J Urol. 2019; 201(2):268\u201376.","journal-title":"J Urol"},{"issue":"5","key":"4792_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","volume":"3","author":"F Giganti","year":"2020","unstructured":"Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V; PRECISION study group. Prostate imaging quality (PI-QUAL): A new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial. Eur Urol Oncol. 2020; 3(5):615\u201319.","journal-title":"Eur Urol Oncol"},{"issue":"7","key":"4792_CR9","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00261-021-03011-0","volume":"46","author":"N Antunes","year":"2021","unstructured":"Antunes N, Vas D, Sebastia C, Salvador R, Ribal MJ, Nicolau C. Susceptibility artifacts and PIRADS 3 lesions in prostatic MRI: how often is the dynamic contrast-enhance sequence necessary? Abdom Radiol (NY). 2021; 46(7):3401\u201309.","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"4792_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.euf.2017.11.010","volume":"5","author":"GA Sonn","year":"2019","unstructured":"Sonn GA, Fan RE, Ghanouni P, et al. Prostate magnetic resonance imaging interpretation varies substantially across radiologists. Eur Urol Focus. 2019; 5(4):592\u201399.","journal-title":"Eur Urol Focus"},{"issue":"1","key":"4792_CR11","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.eururo.2018.03.007","volume":"74","author":"V Panebianco","year":"2018","unstructured":"Panebianco V, Barchetti G, Simone G, et al. Negative multiparametric magnetic resonance imaging for prostate cancer: What\u2019s Next? Eur Urol. 2018; 74(1):48\u201354.","journal-title":"Eur Urol"},{"issue":"1","key":"4792_CR12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","volume":"46","author":"P Donato","year":"2019","unstructured":"Donato P, Roberts MJ, Morton A, et al. Improved specificity with 68Ga PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging. 2019; 46(1):20\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"4792_CR13","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.eururo.2021.08.002","volume":"80","author":"L Emmett","year":"2021","unstructured":"Emmett L, Buteau J, Papa N, et al. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (PRIMARY): A prospective multicentre study. Eur Urol. 2021; 80(6):682\u2013689.","journal-title":"Eur Urol"},{"issue":"6","key":"4792_CR14","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.clgc.2023.06.007","volume":"21","author":"P Pepe","year":"2023","unstructured":"Pepe P, Pennisi M. Targeted biopsy in men high risk for prostate cancer: 68Ga-PSMA PET\/CT versus mpMRI. Clin Genitourin Cancer. 2023;21(6):639\u2013642.","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"4792_CR15","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s00330-016-4635-5","volume":"27","author":"NL Hansen","year":"2017","unstructured":"Hansen NL, Koo BC, Gallagher FA, et al. Comparison of initial and tertiary centre second opinion reads of multiparametric magnetic resonance imaging of the prostate prior to repeat biopsy. Eur Radiol. 2017; 27(6):2259\u20132266.","journal-title":"Eur Radiol"},{"issue":"2","key":"4792_CR16","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.clgc.2018.10.006","volume":"17","author":"S Luzzago","year":"2019","unstructured":"Luzzago S, Petralia G, Musi G, et al. Multiparametric magnetic resonance imaging second opinion may reduce the number of unnecessary prostate biopsies: time to improve radiologists\u2019 training program? Clin Genitourin Cancer. 2019; 17(2):88\u201396.","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"4792_CR17","doi-asserted-by":"publisher","first-page":"5659","DOI":"10.1007\/s00261-021-03268-5","volume":"46","author":"L Hu","year":"2021","unstructured":"Hu L, Wei L, Wang S, Fu C, Benker T, Zhao J. Better lesion conspicuity translates into improved prostate cancer detection: comparison of non-parallel-transmission-zoomed DWI with conventional-DWI. Abdom Radiol (NY). 2021; 46(12):5659\u20135668.","journal-title":"Abdom Radiol (NY)"},{"issue":"19","key":"4792_CR18","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med. 2018; 378(19):1767\u20131777.","journal-title":"N Engl J Med"},{"issue":"1","key":"4792_CR19","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3892\/etm.2014.2061","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen J, Yi XL, Jiang LX, et al. 3-Tesla magnetic resonance imaging improves the prostate cancer detection rate in transrectral ultrasound-guided biopsy. Exp Ther Med. 2014; 9(1):207\u2013212.","journal-title":"Exp Ther Med"},{"issue":"5","key":"4792_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.ejrad.2016.02.020","volume":"85","author":"C Brendle","year":"2016","unstructured":"Brendle C, Martirosian P, Schwenzer NF, et al. Diffusion-weighted imaging in the assessment of prostate cancer: Comparison of zoomed imaging and conventional technique. Eur J Radiol. 2016; 85(5):893\u2013900.","journal-title":"Eur J Radiol"},{"key":"4792_CR21","doi-asserted-by":"crossref","unstructured":"Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360(13):1310\u20131319.","DOI":"10.1056\/NEJMoa0810696"},{"issue":"7","key":"4792_CR22","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1007\/s00330-013-2795-0","volume":"23","author":"F Bratan","year":"2013","unstructured":"Bratan F, Niaf E, Melodelima C, et al. Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study. Eur Radiol. 2013; 23(7):2019\u20132029.","journal-title":"Eur Radiol"},{"issue":"2","key":"4792_CR23","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4081\/aiua.2021.2.139","volume":"93","author":"P Pepe","year":"2021","unstructured":"Pepe P, Candiano G, Pepe L, Pennisi M, Fraggetta F. mpMRI PI-RADS score 3 lesions diagnosed by reference vs affiliated radiological centers: Our experience in 950 cases. Archivio Italiano di Urologia e Andrologia. 2021;93(2):139\u2013142.","journal-title":"Archivio Italiano di Urologia e Andrologia"},{"issue":"1","key":"4792_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.acra.2020.10.019","volume":"29","author":"AS Purysko","year":"2022","unstructured":"Purysko AS, Mielke N, Bullen J, et al. Influence of enema and dietary restrictions on prostate MR image quality: a multireader study. Acad Radiol. 2022; 29(1):4\u201314.","journal-title":"Acad Radiol"},{"issue":"12","key":"4792_CR25","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1007\/s00261-020-02487-6","volume":"45","author":"M Coskun","year":"2020","unstructured":"Coskun M, Mehralivand S, Shih JH, et al. Impact of bowel preparation with Fleet\u2019s\u2122 enema on prostate MRI quality. Abdom Radiol (NY). 2020; 45(12):4252\u20134259.","journal-title":"Abdom Radiol (NY)"},{"issue":"2","key":"4792_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.acra.2020.01.031","volume":"28","author":"J Sackett","year":"2021","unstructured":"Sackett J, Shih JH, Reese SE, et al Quality of prostate MRI: is the PI-RADS standard sufficient? Acad Radiol. 2021; 28(2):199\u2013207.","journal-title":"Acad Radiol"},{"key":"4792_CR27","doi-asserted-by":"publisher","first-page":"110431","DOI":"10.1016\/j.ejrad.2022.110431","volume":"154","author":"N P\u00f6tsch","year":"2022","unstructured":"P\u00f6tsch N, Rainer E, Clauser P, et al. Impact of PI-QUAL on PI-RADS and cancer yield in an MRI-TRUS fusion biopsy population. Eur J Radiol. 2022; 154:110431.","journal-title":"Eur J Radiol"},{"key":"4792_CR28","doi-asserted-by":"publisher","first-page":"111227","DOI":"10.1016\/j.ejrad.2023.111227","volume":"170","author":"AM Pausch","year":"2024","unstructured":"Pausch AM, Ghafoor S, Kluckert J, Rupp NJ, Eberli D, H\u00f6tker AM. Risk factors for prostate cancer in men with false-negative mpMRI: A retrospective single center cohort study of image quality scores and clinical parameters. Eur J Radiol. 2024; 170:111227.","journal-title":"Eur J Radiol"},{"issue":"3","key":"4792_CR29","doi-asserted-by":"publisher","first-page":"415","DOI":"10.21873\/invivo.11075","volume":"31","author":"P Pepe","year":"2017","unstructured":"Pepe P, D\u2019Urso D, Garufi A, et al. Multiparametric MRI apparent diffusion coefficient (ADC) accuracy in diagnosing clinically significant prostate cancer. In Vivo. 2017;31(3):415\u2013418.","journal-title":"In Vivo"},{"issue":"8","key":"4792_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7326\/L17-0738","volume":"168","author":"A Tsodikov","year":"2018","unstructured":"Tsodikov A, Gulati R, Heijnsdijk EAM. Reconciling the effects of screening on prostate cancer mortality in the ERSPC and PLCO Trials. Ann Intern Med. 2018; 168(8):605\u2013606.","journal-title":"Ann Intern Med"},{"issue":"3","key":"4792_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.euo.2018.09.001","volume":"2","author":"L Boesen","year":"2018","unstructured":"Boesen L, N\u00f8rgaard N, L\u00f8gager V, et al. Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7\u201310 Prostate Cancer in Biopsy-na\u00efve Men. Eur Urol Oncol. 2018; 2(3): 311\u2013319.","journal-title":"Eur Urol Oncol"},{"issue":"11","key":"4792_CR32","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.urolonc.2020.05.024","volume":"38","author":"E Stevens","year":"2020","unstructured":"Stevens E, Truong M, Bullen JA, Ward RD, Purysko AS, Klein EA. Clinical utility of PSAD combined with PI-RADS category for the detection of clinically significant prostate cancer. Urol Oncol. 2020; 38(11): 846. e9-846.e16.","journal-title":"Urol Oncol"},{"issue":"6","key":"4792_CR33","doi-asserted-by":"publisher","first-page":"e698-e704","DOI":"10.1016\/j.clgc.2020.04.006","volume":"18","author":"M Roscigno","year":"2020","unstructured":"Roscigno M, Stabile A, Lughezzani G, et al. The use of multiparametric magnetic resonance imaging for follow-up of patients included in active surveillance protocol: can PSA density discriminate patients at different risk of reclassification? Clin Genitourin Cancer. 2020;18(6):e698-e704.","journal-title":"Clin Genitourin Cancer"},{"key":"4792_CR34","doi-asserted-by":"crossref","unstructured":"Nguyen TA, Fourcade A, Zambon A, et al. Optimal PSA density threshold and predictive factors for the detection of clinically significant prostate cancer in patient with a PI-RADS 3 lesion on MRI. Urol Oncol. 2023; 41(8): 354.e11-354.e18.","DOI":"10.1016\/j.urolonc.2023.05.005"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-024-04792-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-024-04792-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T03:56:31Z","timestamp":1757130991000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-024-04792-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,25]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4792"],"URL":"https:\/\/doi.org\/10.1007\/s00261-024-04792-w","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,25]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}